ILT4 and its R20H variant as marker of poor prognosis in Spanish patients with colorectal cancer
{{output}}
Background: Immune checkpoint blockade is proving beneficial for cancer treatment by stimulating the anti-tumor immune response. However, the lack of success in certain cancer types encourages the research of new potential target... ...
